Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines

被引：0
|
作者：
Yasmin M. Attia
Hanan S. EL-Abhar
Mahmoud M. Al Marzabani
Samia A. Shouman
机构：
[1] National Cancer Institute,Pharmacology Unit, Cancer Biology Department
[2] Cairo University,Pharmacology and Toxicology Department, Faculty of Pharmacy
[3] Cairo University,undefined
来源：
BMC Cancer | / 15卷
关键词：
Breast cancer; Tamoxifen; 3-bromopyruvate; Apoptosis; Angiogenesis; MMPs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
    Attia, Yasmin M.
    El-Abhar, Hanan S.
    Al Marzabani, Mahmoud M.
    Shouman, Samia A.
    BMC CANCER, 2015, 15
  • [2] Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
    Cardaci, Simone
    Desideri, Enrico
    Ciriolo, Maria Rosa
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2012, 44 (01) : 17 - 29
  • [3] The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH
    Azevedo-Silva, Joao
    Queiros, Odilia
    Ribeiro, Ana
    Baltazar, Fatima
    Young, Ko H.
    Pedersen, Peter L.
    Preto, Ana
    Casal, Margarida
    BIOCHEMICAL JOURNAL, 2015, 467 : 247 - 258
  • [4] Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
    Simone Cardaci
    Enrico Desideri
    Maria Rosa Ciriolo
    Journal of Bioenergetics and Biomembranes, 2012, 44 : 17 - 29
  • [5] Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate
    Pienkowska, Natalia
    Bartosz, Grzegorz
    Furdak, Paulina
    Sadowska-Bartosz, Izabela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 22
  • [6] 3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines
    Qin, J. -Z.
    Xin, H.
    Nickoloff, B. J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (02) : 495 - 500
  • [7] Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines
    Azab, SS
    El-Demerdash, E
    Abdel-Naim, AB
    Youssef, E
    El-Sharkawy, N
    Osman, AMM
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (05) : 725 - 732
  • [8] Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy
    Azevedo-Silva, J.
    Tavares-Valente, D.
    Almeida, A.
    Queiros, O.
    Baltazar, F.
    Ko, Y. H.
    Pedersen, P. L.
    Preto, A.
    Casal, M.
    MEDICAL ONCOLOGY, 2022, 39 (09)
  • [9] 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells
    Liu, Zhe
    Sun, Yiming
    Hong, Haiyu
    Zhao, Surong
    Zou, Xue
    Ma, Renqiang
    Jiang, Chenchen
    Wang, Zhiwei
    Li, Huabin
    Liu, Hao
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (09): : 2673 - 2685
  • [10] Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line
    Yousefi, Somayeh
    Darvishi, Parisa
    Yousefi, Zeynab
    Pourfathollah, Ali Akbar
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2020, 52 (02) : 103 - 111
12345